Pregnancy after coronary revascularization presents unique challenges to the management of antiplatelet therapy, anesthesia and mode of delivery. We present two cases where women of reproductive age required coronary revascularization with drug eluting stents after a myocardial infarction, and discuss key aspects of pregnancy and labor management.
GholizadehLDavidsonP. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int2008; 29: 3–22.
2.
HamiltonBEMartinJAVenturaSJ. Births: preliminary data for 2011. National vital statistics reports2012; Vol 61. Hyattsville, MD: National Center for Health Statistics.
3.
FoleyMRCardiac disease. In: DildyGABelfortMASaadeGR (eds). Critical care obstetrics, 4th ed. Malden, MA: Blackwell Publishing, 2004, pp. 252.
4.
ClarkSLCottonDBLeeW. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol1989; 161: 1439.
5.
van OppenACStigterRHBruinseHW. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol1996; 87: 310–318.
6.
SiuCSermerMColmanJM. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation2001; 104: 515–521.
7.
BriggsGGFreemanRKYaffeSJ. Drugs in pregnancy and lactation, 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2008.
8.
RosenthalTOparilS. The effect of antihypertensive drugs on the fetus. J Hum Hypertens2002; 16: 293–298.
9.
ButtersLKennedySRubinPC. Atenolol in essential hypertension during pregnancy. BMJ1990; 301: 587–589.
10.
LipGYBeeversMChurchillD. Effect of atenolol on birth weight. Am J Cardiol1997; 79: 1436–1438.
11.
CorbyDG. Aspirin in pregnancy: maternal and fetal effects. Pediatrics1978; 62(Suppl): 930–937.
12.
KlinzingPMarkertURLiesaus PeikerG. Case report: successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidogrel. Clin Exp Obstet Gynecol2001; 28: 215–216.
13.
MyersGRHoffmanMKMarshallES. Clopidogrel use throughout pregnancy in a patient with a drug-eluting coronary stent. Obstet Gynecol2011; 118: 32–33.
14.
De SantisMDe LucaCMappaI. Clopidogrel treatment during pregnancy: a case report and a review of literature. Intern Med2011; 50: 1769–1773.
15.
Cutlip D and Abbott JD. Drug-eluting compared to bare metal intracoronary stents. In: Windecker S and Saperia GM (eds) UpToDate. Waltham, MA, 2013.
16.
BoztosunBOlcayAAvciA. Treatment of acute myocardial infarction in pregnancy with coronary artery balloon angioplasty and stenting: use of tirofiban and clopidogrel. Int J Cardiol2008; 127: 413–416.
17.
Al-AqeediRFAl-NabtiAD. Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel. J Invasive Cardiol2008; 20: E146–E149.
18.
CuthillJAYoungSGreerIA. Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section. Int J Obstet Anesth2005; 14: 167–171.
19.
Tello-MontoliuASeecheranNAAngiolilloDJ. Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice. J Thromb Thrombolysis2013; 36: 348–351.
20.
FeresFCostaRAAbizaidA. Three vs. twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA2013; 310: 2510–2522.
21.
KandzariDEAngiolilloDJPriceMJ. Identifying the “optimal” duration of dual antiplatelet therapy after drug-eluting stent revascularization. JACC Cardiovasc Interv2009; 2: 1279–1285.
